COMMUNIQUÉS West-GlobeNewswire

CGA.vitaslim Announces Mission to Help 5,000 Adults Combat the "Three Highs" and Reclaim Their Health and Wealth in Hong Kong
23/06/2026
HONG KONG, June 23, 2026 (GLOBE NEWSWIRE) -- CGA.vitaslim, a premier health and wellness consultancy, today announced the launch of a new community-focused initiative aimed at helping 5,000 individuals aged 30 to 60 [...]
Transactions in connection with share buy-back program
23/06/2026
Company announcement no. 22 - 26 23 June 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission
23/06/2026
ORION CORPORATION PRESS RELEASE 23 JUNE 2026 at 9:30 EEST Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission Orion Corporation (Orion Pharma) today [...]
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
23/06/2026
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution [...]
Communiqué de presse : Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes
23/06/2026
Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes Cenrifki représente une avancée [...]
Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
23/06/2026
Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) Approval [...]
Nicox et Vester Finance signent une convention d’avance en compte courant d’actionnaire en support des activités stratégiques de la Société
23/06/2026
Communiqué de presse Nicox et Vester Finance signent une convention d’avance en compte courant d’actionnaire en support des activités stratégiques de la Société Convention d’avance en compte courant d’actionnaire pour [...]
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
23/06/2026
Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses Cenrifki represents a significant advancement for people [...]
BienRaíz Launches Vitamin D3 5000 IU Softgels: A High-Potency, Simple Formula for Everyday Wellness
23/06/2026
New Vitamin D3 Supplement Delivers 5000 IU of Cholecalciferol in Easy-to-Take Softgels Designed for Adults Seeking a Flexible Daily Wellness Routine LOS ANGELES, June 23, 2026 (GLOBE NEWSWIRE) -- As more adults spend [...]
Communiqué de presse : Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire
23/06/2026
Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire Wayrilz est un inhibiteur de la BTK qui agit par modulation multi-immune pour aider à traiter les causes sous-jacentes de la [...]
Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company
23/06/2026
Press Release Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company Shareholder loan agreement for up to €6.0 million over 3 years Company is currently well-financed, [...]
argenx to Host Autoimmune Myositis R&D Webinar
23/06/2026
June 23, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will host a [...]
COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
23/06/2026
TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) announced the next steps in connection with changes to the Company’s share capital [...]
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/06/2026
SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/06/2026
BEDFORD, Mass., June 22, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
MoonLake Immunotherapeutics Announces Proposed Public Offering
22/06/2026
ZUG, Switzerland, June 22, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today [...]
Tango Therapeutics Appoints Robert Azelby to Board of Directors
22/06/2026
BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today [...]
Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast
22/06/2026
GARDEN CITY, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
22/06/2026
ALAMEDA, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]

Pages